"Our company's mission resonated with the judges," said Eric Dy, CEO and co-founder. "They understood how our technology could help this underserved market."
Since their inception, Bloomlife has worked hard to form strategic partnerships that further their field of expertise. They have ongoing partnerships with the University of California, San Francisco (UCSF)'s Preterm Birth Initiative and the research teams at Stanford.
With the new funding, Bloomlife is focused on building out its commercialization efforts for its first product, a smart pregnancy wearable that automatically detects and tracks contractions which expectant moms can visualize on their smartphone. With their innovative technology, Bloomlife allows the expectant mom to better understand her body and gain peace of mind throughout the third trimester. "Every pregnancy is unique and expectant moms are looking for validation of what they are feeling. Boomlife provides an objective second opinion," says Eric Dy. Bloomlife's pregnancy wearable is only available through an exclusive Early Access Program on their website www.bloomlife.com until launch. Funding will also be used to accelerate commercialization of next features.
Founded in 2014 by Eric Dy, PhD and Julien Penders, MSc and based in San Francisco with offices in Belgium, Bloomlife is a digital health company designing the future of prenatal care with technology to improve the health of moms and babies. Bloomlife is developing smart pregnancy wearables that measure important health parameters of mom and baby from conception to birth. By combining wearable technology with data analytics, Bloomlife strives to provide moms and clinicians with better information to improve birth outcomes. www.bloomlife.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/womens-digital-health-startup-bloomlife-raises-4m-in-seed-funding-300313912.html